Comparison of Estramustine Phosphate and Vincristine Alone or in Combination for Patients with Advanced, Hormone Refractory, Previously Irradiated Carcinoma of the Prostate-Reference-Cited by-同舟云学术

Comparison of Estramustine Phosphate and Vincristine Alone or in Combination for Patients with Advanced, Hormone Refractory, Previously Irradiated Carcinoma of the Prostate

Published:1981-05 Issue:5 Volume:125 Page:664-667
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Soloway Mark S.¹²³⁴⁵,deKernion Jean B.¹²³⁴⁵,Gibbons Robert P.¹²³⁴⁵,Johnson Douglas E.¹²³⁴⁵,Loening Stefan A.¹²³⁴⁵,Pontes J. Edson¹²³⁴⁵,Prout George R.¹²³⁴⁵,Schmidt Joseph D.¹²³⁴⁵,Scott William W.¹²³⁴⁵,Chu T. Ming¹²³⁴⁵,Gaeta John F.¹²³⁴⁵,Slack Nelson H.¹²³⁴⁵,Murphy Gerald P.¹²³⁴⁵

Affiliation:

1. From the University of Tennessee Center for Health Sciences, Memphis, Tennessee

2. Tulane Medical School, New Orleans, Louisiana;

3. Virginia Mason Medical Center, Seattle, Washington

4. University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Texas

5. University of Iowa Hospitals and Clinics, Iowa City, Iowa

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. American Cancer Society: Cancer Facts & Figures, 1979, American Cancer Society, New York, New York.

2. The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate;Scott;J. Urol.,1976

3. A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation;Murphy;J. Urol.,1977

4. Chemotherapy of prostatic cancer;Schmidt;Urol. Clin. N. Amer.,1975

5. National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report;Johnson;Cancer Treat. Rep.,1977

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond the androgen receptor: New approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting;The Prostate;2014-01-13

2. Antimitotic agents for the treatment of patients with metastatic castrate-resistant prostate cancer;Expert Opinion on Investigational Drugs;2013-04-16

3. Efficacy of estramustine phosphate according to risk classification of castration-resistant prostate cancer;Medical Oncology;2012-02-10

4. Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer;Anti-Cancer Agents in Medicinal Chemistry;2009-12-01

5. Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data;The Lancet Oncology;2007-11